1. Home
  2. ADXN vs BREA Comparison

ADXN vs BREA Comparison

Compare ADXN & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADXN
  • BREA
  • Stock Information
  • Founded
  • ADXN 2002
  • BREA 2022
  • Country
  • ADXN Switzerland
  • BREA Ireland
  • Employees
  • ADXN N/A
  • BREA N/A
  • Industry
  • ADXN Biotechnology: Pharmaceutical Preparations
  • BREA Services-Misc. Amusement & Recreation
  • Sector
  • ADXN Health Care
  • BREA Consumer Discretionary
  • Exchange
  • ADXN Nasdaq
  • BREA Nasdaq
  • Market Cap
  • ADXN 8.0M
  • BREA 8.7M
  • IPO Year
  • ADXN N/A
  • BREA 2023
  • Fundamental
  • Price
  • ADXN $7.75
  • BREA $0.61
  • Analyst Decision
  • ADXN Strong Buy
  • BREA
  • Analyst Count
  • ADXN 1
  • BREA 0
  • Target Price
  • ADXN $30.00
  • BREA N/A
  • AVG Volume (30 Days)
  • ADXN 24.1K
  • BREA 61.7K
  • Earning Date
  • ADXN 03-24-2025
  • BREA 01-03-2025
  • Dividend Yield
  • ADXN N/A
  • BREA N/A
  • EPS Growth
  • ADXN N/A
  • BREA N/A
  • EPS
  • ADXN 0.06
  • BREA N/A
  • Revenue
  • ADXN $701,260.00
  • BREA $2,872,101.00
  • Revenue This Year
  • ADXN N/A
  • BREA N/A
  • Revenue Next Year
  • ADXN N/A
  • BREA N/A
  • P/E Ratio
  • ADXN $1.04
  • BREA N/A
  • Revenue Growth
  • ADXN N/A
  • BREA 2338.69
  • 52 Week Low
  • ADXN $6.81
  • BREA $0.50
  • 52 Week High
  • ADXN $27.90
  • BREA $3.00
  • Technical
  • Relative Strength Index (RSI)
  • ADXN 48.97
  • BREA 40.15
  • Support Level
  • ADXN $7.49
  • BREA $0.62
  • Resistance Level
  • ADXN $7.86
  • BREA $0.68
  • Average True Range (ATR)
  • ADXN 0.44
  • BREA 0.05
  • MACD
  • ADXN 0.01
  • BREA -0.01
  • Stochastic Oscillator
  • ADXN 47.96
  • BREA 14.37

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

About BREA Brera Holdings PLC

Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

Share on Social Networks: